Polypropylene Market Growth and Analysis by 2020-2026 with Profiling Players

The global polypropylene market is anticipated to reach USD 120.11 billion by 2026 according to a new study published by Polaris Market Research. Polypropylene (PP), a thermoplastic is also referred to as addition polymer. It is named so, as it is made with the amalgamation of propylene monomers. The polymer was initially polymerized many years ago, precisely in 1951 by a team of Philips petroleum scientists. The team comprised Robert Banks, Paul Hogan, Natta, and Rehn. The actual commercialization of polypropylene began shortly after Professor Giulio Natta polymerized it.

By 1957, polypropylene gained high popularity throughout Europe and is presently the widely used plastics across the globe. It offers numerous benefits, one of which is its ability to get manufactured thorough ease and at a very large scale. It can be produced through various processes such as CNC, thermoforming, crimping, and injection molding, among others. It can be manufactured into living hinges, making it significantly light and thin without any bend or breaking. Thus, making it ideal for a variety of applications in industries such as automotive, consumer products, manufacturing, and industrial, among others.

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/global-polypropylene-market/request-for-sample

The list of key companies that are operating in the market include LyondellBasell, Japan Polypropylene Corporation, BASF AG, SABIC (Saudi Basic Industries Corporation), Braskem, China Petroleum & Chemical Corporation (Sinopec), Borealis AG, Total Refining and Chemicals Business, INEOS Olefins and Polymers Europe, ExxonMobil Chemical, Reliance Industries Limited, and PetroChina Co. Ltd., among others

Polypropylene can be easily copolymerized with other polymers such as polyethylene. Through copolymerization, significant changes are made to the properties of the material. Moreover, Polypropylene exhibits some significant properties such as high chemical resistance, elasticity, strength, fatigue resistance, transmissivity, and insulation. Thus, allowing large engineering applications, including toys, dishwasher, cups, safe plates, containers, and trays, among others.

Polypropylene has high application in both household and industrial applications. The unique properties and capabilities exhibited by the polymer facilitate varied application. In addition, it can be utilized as a plastic as well as fiber. Moreover, it can be manufactured via a number of processes. Thus, allowing the manufacturer to choose the most profitable procedure. From the past so many years, it is experiencing sustainable growth and is projected to dominate the demand in the plastic industry.

Have some specific queries about this report, our team of analyst will be glad to help! Click here : https://www.polarismarketresearch.com/industry-analysis/global-polypropylene-market/speak-to-analyst

Presently, there are only two types of polypropylene available in the market i.e. homopolymer and copolymers. Homopolymers are the widely used types and acquire a dominant position in the market. While, copolymers are largely utilized for applications that require the production of much clearer, and malleable products.

Currently, Asia Pacific holds a significant market share and is expected to retain its dominant position in the coming next eight years. This is primarily due to the rapidly growing demand for lightweight hybrid electric vehicles to encourage a decrease in carbon emissions.

Peptide Based Cancer Therapeutics Market Growth and Analysis by 2020-2027 with Profiling Players

The global peptide based cancer therapeutics market size is expected to reach USD 17.18 billion by 2027 according to a new study by Polaris Market ResearchPeptides are compounds that are created by natural or artificial biological linking of amino acid monomers. Peptides are being widely used in therapeutics to treat several ailments, including cancer owing to their precision based nature, targeting solid tumor cells in the body. Peptide based cancer therapeutics have shown effective results against cancer as opposed to conventional cancer treatments, without much side effects.

Peptide based therapies in the treatment of cancer are majorly classified as pure play peptide therapy, vaccines based on peptide, and peptide conjugate nanomaterials. These therapies possess several advantages over others such as easy administration, specificity in targeting tumor tissues, fewer side effects as compared to drugs, and low cost of peptides.

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/peptide-based-cancer-therapeutics-market/request-for-sample

Market participants such as AstraZeneca PLC, Abbott, Allergan plc, Teva Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical, Amgen, Inc., Johnson & Johnson, AbbVie Inc., and Valeant Pharmaceuticals Inc., are some of the key players operating in the concerned market. In January 2020, Sony Brook University (SBU) extended its funding on FABP5 inhibitors to 2025 by demonstrating novel approach to treat last stage prostate cancer. According to the researchers of the SBU specific fatty acid binding protein (FABP) may be help in stopping cancer.

In June 2017, AstraZeneca along with National Cancer Institute Eleven entered into cooperative research and development agreement with Eleven Biotherapeutics to develop Vicinium in combination with AstraZeneca’s immune checkpoint inhibitor, Imfinzi to treat non-muscle invasive bladder cancer.

The factors propelling the market growth are the increasing prevalence of cancer across the world, cancer screening programs in emerging countries, and the high specificity of peptide based cancer vaccines. In 2016, according to analysis by NCA (National Cancer Center), 1,010,200 cancer cases were recorded, with 576,100 male patients and 434,100 women cases. The mortality rate in 2016 recorded a high with more than 374,000 cancer deaths in the country, particularly deaths associated with the most common colorectal cancer followed by gastric, lung, prostrate and breast cancers.

Have some specific queries about this report, our team of analyst will be glad to help! Click here : https://www.polarismarketresearch.com/industry-analysis/peptide-based-cancer-therapeutics-market/speak-to-analyst

Percutaneous Coronary Intervention Devices Market Share, Industry Size, Opportunities, Analysis and Forecast To 2027

The global percutaneous coronary intervention (PCI) devices market size is expected to reach USD 11.4 billion by 2027 according to a new study by Polaris Market Research. Coronary artery disease (CAD) is causing most of deaths globally. The factors contributing to the disease include sedentary lifestyle, smoking, obesity, hereditary factors and alcohol usage. The mortality rate of CAD has been tremendously increasing grabbing the attention for researchers and clinicians globally, With the technological advancements in stent technologies, design of the guide wires, advent of next generation  coronary catheters (percutaneous transluminal coronary angioplasty (PTCA), percutaneous transluminal angioplasty (PTA) balloon catheters ), and the availability of coronary guide wires (steel based, nitinol based ) increased the treatment scope of the coronary heart diseases.

Polaris Market research has segmented the percutaneous coronary intervention (PCI) devices market report on the basis of product, end-use and region

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/percutaneous-coronary-intervention-pci-devices-market/request-for-sample

The emergence of dedicated catheterization labs in high income countries is also pivotal factor influencing the growth of the PCI devices market. The next generation Cath labs offers advanced services and performs interventional therapeutic procedures such as PCI, PTCA, epicardial ablations of ventricular tachycardia, aortic valve replacements and mitral valve repairs. Additionally, they also perform interventional cardiac electrophysiological procedures, pacemaker implantation and cardiac defibrillator implantation. The number of PCI procedures and other cardiac interventions is substantially increasing with the increase in the cardiovascular diseases globally.

To increase the performance of multi-specialty hospitals, many government and private hospitals are setting up catheterization labs for improved service offerings. This concept is gaining popularity for PCI procedures in Canada, the US, the UK, Germany, and other western countries. The factors favoring its growth include the conversion of physician’s office to alternate hospital providers, surgeons’ relationship with the manufacturers to eliminate the need of general practitioner officers (GPO), and the expansion of services provided by the hospitals.

Get Exclusive Discount on This Report : https://www.polarismarketresearch.com/industry-analysis/percutaneous-coronary-intervention-pci-devices-market/request-for-discount-pricing

Market participants such as Abbott, B. Braun, ASAHI INTECC Company Limited, Biosensors International Group, Ltd, Boston Scientific Corporation, C. R. Bard, BIOTRONIK, Comed BV, Cook, Meril Lifesciences, Cordis, Medtronic PLC, Merit Medical System, and Terumo Corporation are some of the key players operating in the percutaneous coronary intervention (PCI) devices market. Key vendors are investing huge amounts into their R&D and introducing new technologies and launching new products to stay competitive in this market. Several products were launched in the recent past with the latest next generation technology which caters the growing needs of the physician and the patients.

Legal Marijuana Market Size, Regional Insights, Trends, Revenue & Forecast To 2027

The global Legal Marijuana Market size is expected to be more than USD 90.5 billion by 2027 according to a new study by Polaris Market Research. Increasing penetration of Legal Marijuana in applications other than recreational such as pharmaceuticals, and increasing medical prospects are some of the factors propelling the market growth. Legal Marijuana is being used for treating a wide variety of diseases including cancer, arthritis, neurological conditions, Parkinson’s diseases, among others and this factor is expected to propel market growth.

Pain management therapies segment is witnessing rapid growth across the globe. This therapy is increasingly being used to treat elders suffering from chronic pain. Legal Marijuana are finding wide applications in pain management therapies due to their overall efficacy, easy availability and relatively low prices as compared to other counterparts and this trend is expected to benefit the overall Legalized Cannabis market growth over the forecast period.

Download Sample Copy :  https://www.polarismarketresearch.com/industry-analysis/legal-marijuana-market/request-for-sample

Several studies have pointed out that the usage of Legal Marijuana to treat mental disorders yield desired and positive results. Changes in lifestyle and fast paced lifestyles, advent of nuclear families, social media, among others are some of the factors that have resulted in rising number of mental disorders such as depression, anxiety disorders, Alzheimer’s diseases, etc. This trend is expected to benefit the demand for Legal Marijuana for mental disorder treatment and thus boosting the market growth.

North America emerged as the largest market for Legal Marijuana in the year 2019, and the segment is expected to continue to lead the market in terms of penetration and is also expected to witness a robust growth rate during the forecast period. A major contributor to this scenario is the strong demand from the U.S. There is widespread usage of Legal Marijuana in the country and this has resulted in the U.S. being one of the foremost consumers of Legal Marijuana across the globe.

Many states in the U.S. have issued clear directives as well as regulations pertaining to the usage of Legal Marijuana. This has resulted in widespread generalization pertaining to its usage. Other states which have not yet drafted such regulations, are under constant pressure from advocate groups, associations, among others for doing the same. All in all, the advent of Legal Marijuana is set to have a long-term impact on the food & beverage industry in the country.

Have some specific queries about this report, our team of analyst will be glad to help! Click here : https://www.polarismarketresearch.com/industry-analysis/legal-marijuana-market/speak-to-analyst

Some of the major market participants include Cannabis Sativa, Inc., United Cannabis Corporation., Tikun Olam, Ltd., Tilray., Lexaria Corp., GW Pharmaceuticals, plc., Canopy Growth Corporation., Aurora Cannabis, Aphria, Inc, and Maricann Group, Inc. among others. Broadening of product portfolio, strong analysis of consumer buying behavior, and efforts taken to increase awareness regarding Legal Marijuana usage are some of the key industry scenarios. Companies often have to navigate through different regulations in different parts of the world and have ensure strict compliance to it prior launching their products. In countries such as the U.S., different regulations exist for different states.

Orthopedic Implants Market Forecast (2020-2026): Present Scenario, User Demand, Growth Analysis, Benefits and Regional Overview

Orthopedic implants market size is set to reach USD 6,894.2 million by 2026 growing at a CAGR of 5.1% during the forecast period according to a new study published by Polaris Market Research. The report ‘Orthopedic Implants Market Share, Size, Trends & Industry Analysis Report, By Application (Spinal, Hip, Knee, Dental, Craniomaxillofacial and S.E.T (Sports Medicine, Extremities, and Trauma)) and by Regions, Segment Forecast 2019-2026’ provides a detailed analysis of present market strengths and future market trends.

The prime purpose of orthopedic implants is to support or replace a missing or damaged bone or joint. They come in extremely handy to treat deformities, correct body posture and put straight the normal skeletal function. The market analysis has seen a tectonic shift from traditional surgical procedures to ultra-modern fixations and prosthetics.

Market success of orthopedic Implants is entrenched in a rising geriatric population with an increasing life-span affected by musculoskeletal disorders such as osteoporosis, osteoarthritis and others. Technological innovations also have seen a steady rise in orthopedic medical implants market. Increasing number of joint replacement cases and sport injuries across the globe will catapult market to leading growth.    

Have Questions? Download a sample copy :  https://www.polarismarketresearch.com/industry-analysis/orthopedic-implants-market/request-for-sample

The center for health design has predicted elderly population to double in coming years. For instance; Japan and South Korea have a life expectancy of 83.7 years and 82.3 years respectively. Surplus Government investments in medical industry and supportive Government opinions in use of implants have directed massive growth for market in coming years.

Restraints to the market are the high cost of treatments associated with orthopedic implants and restrictive Government policies that hamper market growth. Developing economies have a lot going for successful growth in the industry by way of lucrative opportunities.     

The global orthopedic medical implants market is segmented into product, biomaterial, type and region. Based on product, it is classified into reconstructive joint replacements, spinal implants, dental implants, trauma and craniomaxillofacial, orthobiologics and others. The Reconstructive Joint replacement market is further subdivided into knee, hip and extremities. Spinal Implants branch into spinal fusion devices, non-fusion devices/motion preservation devices and invasive spinal bone stimulators. Dental Implants are classified into root form and plate form. Trauma is categorized into screws, plates, staples and others. Based on type, the market is segmented into knee, hip, wrist and shoulder, dental, spine, ankle and others.

Product type comprising reconstructive joint replacements had peak market share in orthopedic implants market analysis.  Reason being increase in prevalence of osteoporosis and osteoarthritis, inventions in joints replacements and rich investments by key players’ in R&D. Spinal  Orthopedic Implants segment is tipped to lead market growth in forecast period. Key findings suggest that orthobiologics segment is expected to tap profuse market growth with concurrent rise in demand for advanced therapies, requirement of minimally invasive procedures and patient awareness towards orthobiologics.

Get Offer :  https://www.polarismarketresearch.com/industry-analysis/orthopedic-implants-market/request-for-discount-pricing

Increasing investments by Government in healthcare and in doting company with a well-developed healthcare infrastructure add momentum to market in North America and Canada. Asia Pacific     offers key players operating in market a thriving opportunity due to a high population base, high awareness regarding orthopedic implants, surge in healthcare infrastructure and rise in geriatric population. The key players operating in the orthopedics Implants market include Johnson and Johnson, Zimmer Biomet Holdings, Inc., Stryker Corporation and Medtronic PLC among others.